Excellent outcome of immunomodulation or Bruton’s tyrosine kinase inhibition in highly refractory primary cutaneous diffuse large B-cell lymphoma, leg type

Excellent outcome of immunomodulation or Bruton’s tyrosine kinase inhibition in highly refractory primary cutaneous diffuse large B-cell lymphoma, leg type

Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT) is a rare diffuse large B-cell lymphoma confined to the skin of the legs. The typical presentation is characterized by solitary or multiple growing plaques, usually confined to one leg. We report a case of PCDLBCL-LT of activated...

Full description

Bibliographic Details
Main Authors: Eva Gupta, Joseph Accurso, Jason Sluzevich, David M. Menke, Han W. Tun
Format: Article
Language:English
Published: SAGE Publishing 2015-12-01
Series:Rare Tumors
Subjects:
Cutaneous diffuse large B-cell lymphoma
lenalidomide
ibrutinib
Online Access:http://www.pagepress.org/journals/index.php/rt/article/view/6067

Internet

http://www.pagepress.org/journals/index.php/rt/article/view/6067

Similar Items